NCT04796389

Brief Summary

Rationale: Anxiety is common in critically ill patients, and has likely become more prevalent in the recent decade due to the imperative of the recent PADIS guidelines to use low levels of sedation and strive for wakefulness. Administration of sedative and analgesic medication is often chosen to reduce anxiety, especially when associated with agitation, but especially sedatives are associated with prolonged mechanical ventilation, delirium and muscle wasting and are therefore preferably minimized. Previous studies have suggested positive effects of music interventions on anxiety in the critically ill, next to other physiological signs such as pain. However, management of anxiety has not been included in the PADIS guidelines, and there is lack of evidence to treat it in spite of its growing importance. Therefore, we aim to study the effect of music intervention on anxiety in adult critically ill patients. Objective: The primary objective is to assess the effect of music intervention on the level of anxiety. Study design: A randomized controlled trial. Study population: Adult patients admitted to the intensive care unit, with whom communication is possible (Richmond Agitation Sedation Scale of -2 or higher). Intervention (if applicable): The music group will be offered to listen to music two times per day for three days after inclusion, during 30-60 minutes per session. Chosen music will be based on the preference of the patient. The control group will receive standard of care during the entire study. Main study parameters/endpoints: The primary outcome is the effect of music on the Visual Analogue Scale for anxiety (VAS-A). Secondary outcomes include effect of music on sedation and agitation level, medication requirement, pain, sleep, delirium, heart rate, mean arterial pressure, and ICU memory and experience.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable anxiety

Timeline
Completed

Started Aug 2020

Typical duration for not_applicable anxiety

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 24, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 4, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 12, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

April 13, 2022

Status Verified

April 1, 2022

Enrollment Period

1.3 years

First QC Date

March 4, 2021

Last Update Submit

April 11, 2022

Conditions

Keywords

musicanxietyintensive care unitcritically ill

Outcome Measures

Primary Outcomes (1)

  • Anxiety (VAS-A)

    Measured using the Visual Analogue Scale for Anxiety (VAS-A), on a scale of 0 to 10, in which a higher score means a worse outcome.

    1.5 year

Secondary Outcomes (10)

  • Anxiety (STAI-6)

    1.5 year

  • Sleep quality

    1.5 year

  • Delirium

    1 year

  • Sedative and opioid medication requirement

    1.5 year

  • ICU memory and experience

    1.5 year

  • +5 more secondary outcomes

Other Outcomes (2)

  • ICU length of stay

    1.5 year

  • Mechanical ventilation

    1.5 year

Study Arms (2)

Recorded music

EXPERIMENTAL

Recorded music intervention

Other: Music

Control

NO INTERVENTION

Standard of care

Interventions

MusicOTHER

Preferred music of the participant administered using headphones.

Recorded music

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Expected ICU stay upon randomisation of at least another 48 hours.
  • Written informed consent acquired from the patient or legal representative.

You may not qualify if:

  • Patients with severe hearing impairment, defined as no verbal communication possible.
  • Neurological condition (e.g. severe stroke), when deemed to interfere with processing of music (e.g. not applicable to patients with minor stroke in past medical history without significant residual neurological deficits; those patients could be included).
  • Insufficient knowledge of the Dutch or English language for informed consent.
  • Participation in another study that may possibly intervene with the primary outcome measure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Erasmus MC

Rotterdam, South Holland, 3015 GD, Netherlands

Location

Ikazia

Rotterdam, South Holland, 3083 AN, Netherlands

Location

HagaZiekenhuis

The Hague, South Holland, 2545 AA, Netherlands

Location

Related Publications (2)

  • Kakar E, Ottens T, Stads S, Wesselius S, Gommers DAMPJ, Jeekel J, van der Jagt M. Effect of a music intervention on anxiety in adult critically ill patients: a multicenter randomized clinical trial. J Intensive Care. 2023 Aug 17;11(1):36. doi: 10.1186/s40560-023-00684-1.

  • Kakar E, Van Mol M, Jeekel J, Gommers D, van der Jagt M. Study protocol for a multicentre randomised controlled trial studying the effect of a music intervention on anxiety in adult critically ill patients (The RELACS trial). BMJ Open. 2021 Oct 12;11(10):e051473. doi: 10.1136/bmjopen-2021-051473.

MeSH Terms

Conditions

Anxiety DisordersCritical Illness

Interventions

Music Therapy

Condition Hierarchy (Ancestors)

Mental DisordersDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Sensory Art TherapiesComplementary TherapiesTherapeuticsRehabilitationAftercareContinuity of Patient CarePatient CarePsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Mathieu Dr. M. van der Jagt, MD, PhD

    Erasmus Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 4, 2021

First Posted

March 12, 2021

Study Start

August 24, 2020

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

April 13, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations